KZIA · Kazia Therapeutics Ltd · Financials
Market Cap
$127.87M
Shares
11.43M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
42K
-98.2%
FY2025
Net Income
-20.7M
+22.7%
FY2025
Operating Cash Flow
-13.28M
-38.6%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| AUD | 42K | 2.31M | 0 | 0 | 15.18M | — | — | 119K | 249K | 406K |
| AUD | 7.33M | 17.38M | 15.56M | 20.17M | 14.54M | 9.49M | 6.48M | 9.77M | 11.14M | 9.89M |
| AUD | 934K | 1.87M | 1.87M | 1.87M | — | 1.08M | 1.08M | 1.55M | 1.42M | 643K |
| AUD | — | — | — | — | — | — | — | — | 765K | — |
| AUD | -22.45M | -27.05M | -20.74M | -25.38M | -8.9M | -12.77M | -10.57M | -6.34M | -10.87M | -12.16M |
| AUD | -1.75M | -271K | -271K | -368K | -484K | -298K | -298K | -305K | -199K | — |
| AUD | -20.7M | -26.78M | -20.47M | -25.01M | -8.42M | -12.47M | -10.27M | -6.04M | -10.67M | -12.06M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2017–FY2025: $0 in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.